You have 9 free searches left this month | for more free features.

Dimethyl Sulfoxide

Showing 1 - 25 of 184

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Dental Diseases Trial in Cairo (Dimethyl Sulfoxide, 3M ESPE Single bond 2, Filtek Z350 XT, 3 M ESPE, St Paul, MN, USA))

Active, not recruiting
  • Dental Diseases
  • Dimethyl Sulfoxide
  • +3 more
  • Cairo, Egypt
    Faculty of Dentistry, Cairo University
Oct 22, 2021

Mild to Moderate Anterior Mandibular Segment Crowdind Trial in Latakia (Dihydroxycholecalciferols, dimethyl sulfoxide, serum)

Completed
  • Mild to Moderate Anterior Mandibular Segment Crowdind
  • Latakia, Syrian Arab Republic
    Tishreen University - Faculty of dentistry
Sep 26, 2022

Interstitial Cystitis, Painful Bladder Syndrome Trial (bupivacaine, triamcinolone, and heparin (BTH), dimethyl sulfoxide (DMSO))

Completed
  • Interstitial Cystitis
  • Painful Bladder Syndrome
  • bupivacaine, triamcinolone, and heparin (BTH)
  • dimethyl sulfoxide (DMSO)
  • (no location specified)
Jan 24, 2022

Thrombocytopenia Trial in Lebanon, Cincinnati, Seattle (CPP, LSP)

Completed
  • Thrombocytopenia
  • CPP
  • LSP
  • Lebanon, New Hampshire
  • +3 more
May 19, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib

Active, not recruiting
  • Advanced Lymphoma
  • +5 more
  • Trametinib Dimethyl Sulfoxide
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Aug 13, 2022

Radiation Dermatitis, Radiation Dermatitis Acute, Breast Cancer Trial in Copenhagen (Melatonin, Dimethyl Sulfoxide, Placebos)

Completed
  • Radiation Dermatitis
  • +2 more
  • Copenhagen, Capital Region, Denmark
    Rigshospitalet
Sep 9, 2021

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in United States (Dabrafenib Mesylate, Tazemetostat

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • Metastatic Melanoma
  • Dabrafenib Mesylate
  • +2 more
  • Atlanta, Georgia
  • +6 more
Nov 30, 2022

BRAF V600E Mutation Trial run by the NHGRI (Dabrafenib Mesylate, Trametinib Dimethyl Sulfoxide)

Completed
  • BRAF V600E Mutation
  • Dabrafenib Mesylate
  • Trametinib Dimethyl Sulfoxide
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 6, 2021

Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial

Active, not recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Dabrafenib Mesylate
  • +3 more
  • Philadelphia, Pennsylvania
    Perelman Center for Advanced Medicine
Dec 29, 2021

Erdheim-Chester Disease Trial in Houston (Dabrafenib Mesylate, Quality-of-Life Assessment, Questionnaire Administration)

Withdrawn
  • Erdheim-Chester Disease
  • Dabrafenib Mesylate
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 16, 2021

Low Grade Glioma (LGG) of Brain With BRAF Aberration, High Grade Glioma (HGG) of the Brain With BRAF Aberration, Low Grade

Recruiting
  • Low Grade Glioma (LGG) of Brain With BRAF Aberration
  • +2 more
  • Phoenix, Arizona
  • +12 more
Apr 7, 2022

Melanoma (Skin) Trial in Charlottesville (biological, drug, procedure)

Completed
  • Melanoma (Skin)
  • incomplete Freund's adjuvant
  • +6 more
  • Charlottesville, Virginia
    University of Virginia Cancer Center
Mar 26, 2020

Systemic Lupus Erythematosus (SLE) Trial (Blood sample, Urine sample, Saliva sample)

Not yet recruiting
  • Systemic Lupus Erythematosus (SLE)
  • Blood sample
  • +4 more
  • (no location specified)
Jul 12, 2022

3TR Systemic Lupus Erythematosus Study Protocol 2

Not yet recruiting
  • Systemic Lupus Erythematosus (SLE)
  • Blood sample
  • +4 more
  • (no location specified)
Feb 17, 2023

Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

Recruiting
  • Lymphoma
  • BEAM Protocol
  • CEM protocol
  • Cairo, Egypt
    International Medical Center (IMC) Hospital, Cairo, Egypt.
Apr 1, 2023

Analgesia Trial in United States (HTX-011, Luer Lock Applicator, Ibuprofen)

Completed
  • Analgesia
  • Sheffield, Alabama
  • +3 more
Mar 11, 2022

Wounds and Injuries Trial in Thessaloniki, Mashhad (Platelet-Rich Plasma-Fibrin Glue, Repairing Gel, Repairing Gel and

Recruiting
  • Wounds and Injuries
  • Platelet-Rich Plasma-Fibrin Glue
  • +3 more
  • Thessaloniki, Greece
  • +1 more
Aug 1, 2023

SARS-CoV-2 Trial in Worldwide (Upamostat, Placebo (PO))

Not yet recruiting
  • SARS-CoV-2
  • Baltimore, Maryland
  • +5 more
Jul 19, 2023

Oral Cancer Trial in Cairo (Quercetin 3,3',4',5,6-Pentahydroxyflavone,

Not yet recruiting
  • Oral Cancer
  • Quercetin 3,3',4',5,6-Pentahydroxyflavone, 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one
  • +2 more
  • Cairo, Egypt
    11 Saraya El Manial
Jul 8, 2022

Osteoarthritis Pain Trial (Etoricoxib 75 mg 4% DMSO Gel, Etoricoxib 75 mg 4% PG Gel, Etoricoxib 150 mg 4% DMSO Gel)

Completed
  • Osteoarthritis Pain
  • Etoricoxib 75 mg 4% DMSO Gel
  • +7 more
  • (no location specified)
Feb 7, 2022

Hypersensitivity, Hay Fever, Rhinitis, Allergic, Seasonal Trial (Polvac Grass+Rye)

Not yet recruiting
  • Hypersensitivity
  • +3 more
  • Polvac Grass+Rye
  • (no location specified)
Jul 17, 2023

Hypoproliferative Thrombocytopenia Trial in Singapore (Control arm receiving normal (never before frozen) platelets as per

Completed
  • Hypoproliferative Thrombocytopenia
  • Control arm receiving normal (never before frozen) platelets as per current clinical practice
  • Treatment arm receiving cryopreserved platelets
  • Singapore, Singapore
    Singapore General Hospital
Sep 23, 2021

Malignant Melanoma, Metastatic, Non Small Cell Lung Cancer Metastatic, Bladder Urothelial Carcinoma, Metastatic Trial in Herlev

Active, not recruiting
  • Malignant Melanoma, Metastatic
  • +2 more
  • Herlev, Denmark
  • +1 more
Jan 10, 2022

Critical Limb Ischemia, Peripheral Arterial Disease Trial in Kuala Lumpur (Stempeucel®)

Not yet recruiting
  • Critical Limb Ischemia
  • Peripheral Arterial Disease
  • Stempeucel®
  • Kuala Lumpur, Malaysia
    Hospital Canselor Tunku Mukhriz
May 2, 2023

Critical Limb Ischemia, Buerger's Disease Trial in Kuala Lumpur (Adult human bone marrow derived, cultured, pooled, allogeneic

Not yet recruiting
  • Critical Limb Ischemia
  • Buerger's Disease
  • Adult human bone marrow derived, cultured, pooled, allogeneic mesenchymal stromal cells
  • Kuala Lumpur, Malaysia
    Hospital Canselor Tunku Mukhriz
May 2, 2023